Meeting
2016 Gastrointestinal Cancers Symposium
A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer.
Authors
David Bing Zhen
University of Michigan, Ann Arbor, MI
David Bing Zhen , Kent A. Griffith , Joshua Michael Ruch , Meredith Morgan , Edward Jae-hoon Kim , Vaibhav Sahai , Diane M. Simeone , Mark Zalupski
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT01663272
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 334)
DOI
10.1200/jco.2016.34.4_suppl.334
Abstract #
334
Poster Bd #
G14
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A phase I trial of elimusertib in combination with cisplatin or with cisplatin plus gemcitabine in advanced solid tumors with an emphasis on urothelial carcinoma.
First Author: Ryan Leibrandt
Poster
2020 ASCO Virtual Scientific Program
Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors.
First Author: Jasmine Huynh
Poster
2019 ASCO Annual Meeting
Phase I trial of chloroquine (CQ)/hydroxychloroquine (HCQ) in combination with carboplatin-gemcitabine (CG) in patients with advanced solid tumors.
First Author: Nagla Fawzy Abdel Karim
Poster
2019 Gastrointestinal Cancers Symposium
A phase I study of mesothelin-targeted immunotoxin LMB-100 in combination with nab-paclitaxel for patients with previously treated advanced pancreatic cancer.
First Author: Christine Campo Alewine